The novel therapy of the medication represents a exciting advance in the handling of type 2 diabetes. Distinct from existing drugs, tirzepatide targets two pathways – the GLP-1 hormone and GIP – providing enhanced https://tirzepatide-peptide039133.digiblogbox.com/66410187/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment